Home/Filings/4/0001235802-17-000161
4//SEC Filing

MENSINK KEVIN L 4

Accession 0001235802-17-000161

CIK 0001374128other

Filed

Oct 23, 8:00 PM ET

Accepted

Oct 24, 4:19 PM ET

Size

9.0 KB

Accession

0001235802-17-000161

Insider Transaction Report

Form 4
Period: 2017-10-20
MENSINK KEVIN L
VICE PRESIDENT, MARKETING
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-10-20$1.24/sh2,500$3,10058,900 total
    Exercise: $1.24Exp: 2023-04-08Common Stock (2,500 underlying)
  • Exercise/Conversion

    Common Stock, $0.001 par value

    2017-10-20$1.24/sh+2,500$3,10010,000 total
  • Sale

    Common Stock, $0.001 par value

    2017-10-20$19.00/sh2,500$47,5007,500 total
Footnotes (3)
  • [F1]Includes 7,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan.
  • [F2]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  • [F3]This option vested as to twenty-five percent (25%) of the shares underlying the option on April 8, 2014, with the remaining shares vesting in 36 substantially equal monthly installments on each monthly anniversary of the grant date thereafter, subject to continued employment or service with the Issuer through each applicable vesting date.

Issuer

ENTELLUS MEDICAL INC

CIK 0001374128

Entity typeother

Related Parties

1
  • filerCIK 0001626343

Filing Metadata

Form type
4
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 4:19 PM ET
Size
9.0 KB